EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Pancreatoduodenectomy versus total pancreatectomy and simultaneous intraportal islet autotransplantation for periampullary cancer at high-risk of postoperative pancreatic fistula (XANDTX-trial): Protocol of a randomized controlled pilot trial

Sebastian Hempel iD, Fiona R Kolbinger iD, Florian Oehme, Olga Radulova-Mauersberger, Janine Schmid, Undine Schubert, Florian Schepp, Stefan Bornstein, Sandra Korn, Evelyn Trips, Jürgen Weitz, Marius Distler und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0327949 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Sebastian Hempel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden,…. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Pancreaticoduodenectomy, Pancreatectomy, Pancreatic Fistula. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nationales Centrum für Tumorerkrankungen Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic surgery remains associated with significant morbidity. Pancreatoduodenectomy (PD) with high-risk stigmata for postoperative pancreatic fistula (POPF) may delay or hinder administration of adjuvant therapy. Total pancreatectomy (TP) prevents POPF-associated complications but implies permanent exocrine and endocrine insufficiency. Islet autotransplantation (IAT) has the potential to compensate endocrine function. Methods and analysis XANDTX is a single-centre randomized controlled pilot trial comparing high-risk PD with TP and simultaneous IAT in patients with periampullary cancer. After screening for eligibility and obtaining informed consent, a total of 32 adult patients will be intraoperatively randomized in a 1:1 ratio. The primary hypothesis is that TP with IAT prevents POPF-associated complications and leads to a shorter period to initiation of adjuvant therapy and a higher overall rate of adjuvant therapy administration. Secondary endpoints include perioperative morbidity and mortality, metabolic outcome, quality of life (QoL) and oncological long-term outcome. Each patient will be followed up for 5 years.

Discussion

The XANDTX pilot trial will aim to provide surgical and oncological feasibility and safety data of total pancreatectomy with simultaneous islet autotransplantation in management of resectable periampullary cancer. The results will form the basis for a further confirmatory controlled study.

Trial registration

This study was registered on ClinicalTrials.gov (NCT05843877) on February 27, 2023 and EudraCT (2023-507773-17-00) on April 18, 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationPancreaticoduodenectomyPancreatectomyPancreatic FistulaPostoperative ComplicationsPancreatic NeoplasmsHumansPilot ProjectsMaleTransplantation, AutologousFemaleAdultMiddle AgedQuality of LifeAgedRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
  • German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
  • Department of Medicine III, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

ORCID-Profile: Sebastian Hempel, Fiona R Kolbinger

Förderung

  • Nationales Centrum für Tumorerkrankungen Heidelberg

Zitieren

APA

Hempel, S., Kolbinger, F. R., Oehme, F., Radulova-Mauersberger, O., Schmid, J., Schubert, U., Schepp, F., Bornstein, S., Korn, S., Trips, E., Weitz, J., Distler, M., & Ludwig, B. (2025). Pancreatoduodenectomy versus total pancreatectomy and simultaneous intraportal islet autotransplantation for periampullary cancer at high-risk of postoperative pancreatic fistula (XANDTX-trial): Protocol of a randomized controlled pilot trial. PLOS One. https://doi.org/10.1371/journal.pone.0327949

Vancouver

Hempel S, Kolbinger FR, Oehme F, Radulova-Mauersberger O, Schmid J, Schubert U, et al. Pancreatoduodenectomy versus total pancreatectomy and simultaneous intraportal islet autotransplantation for periampullary cancer at high-risk of postoperative pancreatic fistula (XANDTX-trial): Protocol of a randomized controlled pilot trial. PLOS One. 2025. doi:10.1371/journal.pone.0327949

BibTeX
@article{Hempel2025,
  author = {Hempel, Sebastian and Kolbinger, Fiona R and Oehme, Florian and Radulova-Mauersberger, Olga and Schmid, Janine and Schubert, Undine and Schepp, Florian and Bornstein, Stefan and Korn, Sandra and Trips, Evelyn and Weitz, Jürgen and Distler, Marius and Ludwig, Barbara},
  title = {Pancreatoduodenectomy versus total pancreatectomy and simultaneous intraportal islet autotransplantation for periampullary cancer at high-risk of postoperative pancreatic fistula (XANDTX-trial): Protocol of a randomized controlled pilot trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327949}
}
Kostenlos starten →